WallStreetZenWallStreetZen

NASDAQ: DSGN
Design Therapeutics Inc Stock Ownership - Who owns Design Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Design Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Arsani WilliamDirector2025-08-13345,000$5.25
$1.81MSell
Arsani WilliamDirector2025-08-13217,627$5.25
$1.14MSell

1 of 1

DSGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DSGN insiders and whales buy or sell their stock.

DSGN Shareholders

What type of owners hold Design Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Simeon George19.71%12,152,952$122.99MInsider
Sr One Capital Fund I Aggregator LP10.58%6,526,476$66.05MInsider
Sr One Capital Management LP10.58%6,526,476$66.05MInstitution
Arsani William9.22%5,687,501$57.56MInsider
Point72 Asset Management LP8.71%5,372,004$54.36MInstitution
Cormorant Asset Management LP8.29%5,114,844$51.76MInsider
Quan Venture Fund II LP7.65%4,720,830$47.77MInsider
Stella Xu6.71%4,139,950$41.90MInsider
Logos Global Management LP4.05%2,500,000$25.30MInstitution
Baker Bros Advisors LP3.62%2,233,099$22.60MInstitution

1 of 3

DSGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DSGN48.39%51.61%Net Selling
TECX26.30%73.70%Net BuyingNet Buying
DRTS2.58%0.00%
LBRX76.06%23.94%Net Buying
MDXG46.84%53.16%Net BuyingNet Buying
View Top Biotech Stocks

Design Therapeutics Stock Ownership FAQ

Who owns Design Therapeutics?

Design Therapeutics (NASDAQ: DSGN) is owned by 61.85% institutional shareholders, 65.98% Design Therapeutics insiders, and 0.00% retail investors. Simeon George is the largest individual Design Therapeutics shareholder, owning 12.15M shares representing 19.71% of the company. Simeon George's Design Therapeutics shares are currently valued at $122.99M.

If you're new to stock investing, here's how to buy Design Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.